Nanoconjugated vancomycin: New opportunities for the development of anti-VRSA agents

Nanotechnology

Volumn 21, Issue 10, 2010, Pages

  Chakraborty, Subhankari Prasad ^a   Sahu, Sumanta Kumar ^b   Mahapatra, Santanu Kar ^a   Santra, Susmita ^b   Bal, Manjusri ^c   Roy, Somenath ^a   Pramanik, Panchanan ^b  

^a VIDYASAGAR UNIVERSITY   (India)

^b INDIAN INSTITUTE OF TECHNOLOGY   (India)

^c UNIVERSITY OF CALCUTTA   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL CELLS; BACTERICIDAL EFFECTS; CHITOSAN DERIVATIVES; CHITOSAN NANOPARTICLES; CONCENTRATION OF; DRUG ACTION; FOLIC ACIDS; GLYCOPEPTIDE ANTIBIOTICS; METHICILLIN; MINIMUM INHIBITORY CONCENTRATION; NANO-SIZED; NANOCONJUGATES; NEW OPPORTUNITIES; PEPTIDOGLYCANS; TOLERANCE VALUES; TROJAN HORSE; VANCOMYCIN;

AMIDES; ANTIBIOTICS; AUTOMOBILE EXHIBITIONS; BIODEGRADABLE POLYMERS; CHITIN; CHITOSAN; ORGANIC ACIDS;

NANOPARTICLES;

BIOMATERIAL; DRUG CARRIER; FOLIC ACID; NANOPARTICLE; POLYMER; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECT; NANOTECHNOLOGY; STAPHYLOCOCCUS AUREUS; SYNTHESIS;

BIOCOMPATIBLE MATERIALS; DRUG CARRIERS; FOLIC ACID; MOLECULAR STRUCTURE; NANOPARTICLES; NANOTECHNOLOGY; POLYMERS; STAPHYLOCOCCUS AUREUS; VANCOMYCIN; VANCOMYCIN RESISTANCE;

EID: 77149164741     PISSN: 09574484     EISSN: 13616528     Source Type: Journal    
DOI: 10.1088/0957-4484/21/10/105103     Document Type: Article

References (29)

1. Archer G L 1998 Clin. Infect. Dis. 26 1179-81
2. Chambers H F 2001 Emerg. Infect. Dis. 7 178-82
3. Dickgiesser N and Kreiswirth B N 1986 Antimicrob. Agents Chemother. 29 930-2
4. Levin T P, Suh B, Axelrod P, Truant A L and Fekete T 2005 Antimicrob. Agents Chemother. 49 1222-4
5. Munckhof W J, Harper J, Schooneveldt J and Nimmo G R 2002 Med. J. Aust. 176 243-4
6. Schmitz F J, Sadurski R, Kray A, Boos M, Geisel R, Kohrer K, Verhoef J and Fluit A C 2000 J. Antimicrob. Chemother. 45 891-4
7. Jevons M P 1961 Br. Med. J. 1 124-5
8. Hiramatsu K, Hanaki H, Ino T and Tenover F C 1997 J. Antimicrob. Chemother. 40 135-46
9. Chang S et al 2003 New Engl. J. Med. 348 1342-7
10. Centers for Disease Control Prevention 1997 Morb. Mortal. Wkly Rep. 46 765-6
11. Centers for Disease Control Prevention 2004 MMWR Morb. Mortal. Wkly Rep. 53 322-3
12. Tiwari H K and Sen M R 2006 BMC Infect. Dis. 6 156-62
13. Kim M N, Pai C H, Woo J H, Ryu J S and Hiramatsu K 2000 J. Clin. Microbiol. 38 3879-81
14. Tenover F C et al 2004 Antimicrob. Agents Chemother. 48 275-80
15. Weigel L M et al 2007 Antimicrob. Agents Chemother. 51 231-8
16. Perichon B and Courvalin P 2006 Antimicrob. Agents Chemother. 50 3622-30
17. Saha B, Singh A K, Ghosh A and Bal M 2008 J. Med. Microbiol. UK Soc. Med. Microbiol. 57 72-9
18. Kell A J, Stewart G, Ryan S, Peytavi R, Boissinot M and Huletsky A 2008 ACS Nano 2 1777-85
19. Hachicha W, Kodjikian L and Fessi H 2006 Int. J. Pharm. 324 176-82
20. Hongwei G, Pak-Leung H, Kenneth W, Tsang T, Ling W and Bing X 2003 J. Am. Chem. Soc. 125 15702-6
21. Turos E, Reddy S K G, Greenhalgh K, Ramaraju P, Abeylath S C, Jang S, Dickey S and Lim D V 2007 Bioorg. Med. Chem. Lett. 17 3468-72
22. Mohapatra S, Mallick S K, Maiti T K, Ghosh S K and Pramanik P 2007 Nanotechnology 18 385102
23. Carlos P, Monal W A, Hazel P and Acosta N 2003 Macromol. Biosci. 3 511-5
24. Le Ray A M, Chiffoleau S, Iooss P, Grimandi G, Gouyette A, Daculsi G and Merle C 2003 Biomaterials 24 443-9
25. NCCLS 2000 Approved Standard M7-A5 vol 17, no. 2 5th edn (Wayne, PA: NCCLS)
26. Ericsson H M and Sherris J C 1971 Acta Pathol. Microbiol. Scand B 217 1-10
27. May J, Shannon K and King A 2006 J. Antimicrob. Chemother. 42 189-97
28. Jones G J R 1996 Adv. Drug. Deliv. Rev. 20 83-97
29. Tamai I and Tsuji A 1996 Adv. Drug. Deliv. Rev. 20 5-12